The Scientist

» NIH and immunology

Most Recent

image: Federally Funded Researchers Fear Shutdown Delays

Federally Funded Researchers Fear Shutdown Delays

By | October 2, 2013

As the US government shutdown enters its second day, scientists who rely on federal grants to continue their work and support their staffs and students express frustration. 

0 Comments

image: Government Shutdown to Impact Science

Government Shutdown to Impact Science

By | October 1, 2013

The failure of the US Congress to reach consensus on a stopgap spending plan threatens to hobble research at federal agencies and beyond.

0 Comments

image: Framingham Heart Study Gutted

Framingham Heart Study Gutted

By | August 26, 2013

The iconic Framingham Heart Study, the longest-running cardiovascular study in the country, has been hit with a $4 million budget cut.

2 Comments

image: Q&A: NIH Brokers HeLa Genome Deal

Q&A: NIH Brokers HeLa Genome Deal

By | August 7, 2013

Officials at the government agency hammer out an agreement with the Lacks family to provide restricted access to genomes of their relative’s unwittingly donated cells.

5 Comments

image: Dermatologist Censured for Plagiarism

Dermatologist Censured for Plagiarism

By | August 6, 2013

A Case Western dermatologist has admitted to plagiarizing a grant she reviewed, plus taking text from eight research papers and a patent application.

0 Comments

image: Opinion: A Diverse Perspective

Opinion: A Diverse Perspective

By | July 29, 2013

Progress in science is dependent on the diversity of its workforce.

3 Comments

image: How the NIH Fuels Private Business

How the NIH Fuels Private Business

By | July 25, 2013

A new report details the ways in which the federal science agency boost the US economy by stimulating the private sector.

0 Comments

image: Stricter Stem Cell Guidelines Sought

Stricter Stem Cell Guidelines Sought

By | July 25, 2013

A new working group is seeking to define rigorous standards for the study of mesenchymal stem cells.

10 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Good Budget News for Govt. Science

Good Budget News for Govt. Science

By | July 11, 2013

Congress subcommittees have proposed increased funding for NIH and NSF.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech